SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-7.37%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$198M
AUM Growth
+$198M
(-21%)
Cap. Flow
-$31M
Cap. Flow
% of AUM
-15.65%
Top 10 Holdings %
Top 10 Hldgs %
42%
Holding
45
New
2
Increased
14
Reduced
10
Closed
11
Top Buys
| 1 |
DexCom
DXCM
|
$4.67M |
| 2 |
HCA Healthcare
HCA
|
$3.69M |
| 3 |
Novo Nordisk
NVO
|
$3.64M |
| 4 |
Insulet
PODD
|
$3.19M |
| 5 |
UnitedHealth
UNH
|
$2.52M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$11M |
| 2 |
Becton Dickinson
BDX
|
$7.92M |
| 3 |
Elevance Health
ELV
|
$6.66M |
| 4 |
Abbott
ABT
|
$6.54M |
| 5 |
Merck
MRK
|
$5.77M |
Sector Composition
| 1 | Healthcare | 96.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.42M | 2.24% |
50,000
| – | – |
|
27
Vertex Pharmaceuticals
VRTX
$102B
| $4.33M | 2.19% |
12,460
-1,540
| -11% | -$536K |
|
28
Avantor
AVTR
$9.01B
| $3.79M | 1.92% |
180,000
+105,000
| +140% | +$2.21M |
|
|
CTLT
29
DELISTED
CATALENT, INC.
CTLT
| $3.64M | 1.84% |
80,000
+10,000
| +14% | +$455K |
|
30
IQVIA
IQV
$31.3B
| $3.44M | 1.74% |
17,500
-10,000
| -36% | -$1.97M |
|
|
31
Insulet
PODD
$24.2B
| $3.19M | 1.61% |
+20,000
| New | +$3.19M |
|
32
Icon
ICLR
$13.7B
| $2.46M | 1.24% |
10,000
-10,000
| -50% | -$2.46M |
|
33
Stevanato
STVN
$6.16B
| $2.26M | 1.14% |
76,072
+6,072
| +9% | +$180K |
|
|
34
Abbott
ABT
$228B
| – | – |
-60,000
| Closed | -$6.54M |
|
35
Alnylam Pharmaceuticals
ALNY
$58.9B
| – | – |
-8,000
| Closed | -$1.52M |
|
36
argenx
ARGX
$42.9B
| – | – |
-3,000
| Closed | -$1.17M |
|
|
37
Becton Dickinson
BDX
$54.1B
| – | – |
-30,000
| Closed | -$7.92M |
|
38
Biogen
BIIB
$20B
| – | – |
-10,000
| Closed | -$2.85M |
|
39
Charles River Laboratories
CRL
$7.89B
| – | – |
-13,000
| Closed | -$2.73M |
|
40
Community Health Systems
CYH
$388M
| – | – |
-300,000
| Closed | -$1.32M |
|
|
41
Elevance Health
ELV
$72.6B
| – | – |
-15,000
| Closed | -$6.66M |
|
42
Grifois
GRFS
$6.6B
| – | – |
-62,843
| Closed | -$576K |
|
|
43
Merck
MRK
$213B
| – | – |
-50,000
| Closed | -$5.77M |
|
44
SPDR S&P 500 ETF Trust
SPY
$650B
| – | – |
0
| – | – |
|
45
Sarepta Therapeutics
SRPT
$1.81B
| – | – |
-811
| Closed | -$93K |
|